ProPhase Labs, Inc. (PRPH)

ProPhase Labs Market Cap

ProPhase Labs has a market cap or net worth of $15.25 million as of June 27, 2025. Its market cap has decreased by -82.73% in one year.

• Market Cap: 15.25M
• Enterprise Value: 29.16M
• 1-Year Change: -82.73%
• Ranking: #4993
• Category: Nano-Cap
• Stock Price: $0.37

Market Cap Chart

Since December 1, 1998, ProPhase Labs's market cap has decreased from $92.00M to $15.25M, a decrease of -83.43%. That is a compound annual growth rate of -6.54%.

Market Cap History

Date	Market Cap	% Change
Jun 27, 2025	15.20M	-16.02%
Dec 31, 2024	18.10M	-77.82%
Dec 29, 2023	81.60M	-47.96%
Dec 30, 2022	156.80M	41.01%
Dec 31, 2021	111.20M	4.41%
Dec 31, 2020	106.50M	367.11%
Dec 31, 2019	22.80M	-37.36%
Dec 31, 2018	36.40M	34.81%
Dec 29, 2017	27.00M	-21.05%
Dec 30, 2016	34.20M	33.59%
Dec 31, 2015	25.60M	13.27%
Dec 31, 2014	22.60M	-11.72%
Dec 31, 2013	25.60M	26.73%
Dec 31, 2012	20.20M	19.53%
Dec 30, 2011	16.90M	-3.98%
Dec 31, 2010	17.60M	-30.98%
Dec 31, 2009	25.50M	-50.58%
Dec 31, 2008	51.60M	-15.69%
Dec 31, 2007	61.20M	-15.24%
Dec 29, 2006	72.20M	-55.24%
Dec 30, 2005	161.30M	64.42%
Dec 31, 2004	98.10M	-19.85%
Dec 31, 2003	122.40M	94.29%
Dec 31, 2002	63.00M	156.10%
Dec 31, 2001	24.60M	179.55%

View and export this data all the way back to 1998. Sign Up Today.

Related Stocks

Company	Market Cap
Eli Lilly and Company	714.77B
Johnson & Johnson	366.37B
AbbVie	330.35B
Novo Nordisk	301.06B
UnitedHealth Group	274.29B
Novartis AG	235.02B
Abbott Laboratories	232.51B
AstraZeneca	216.45B